Product Details

Mint-Zolmitriptan

Zolmitriptan
2.5 mg
Tablet


DIN/PIN/NPN

02419521

Manufacturer

Mint Pharmaceuticals Inc.

Formulary Listing Date

2014-05-29  

Unit Price

6.8583

Amount MOH Pays

6.8583

Coverage Status

Off-Formulary Interchangeable Exceptional Access Program Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

N02CC03

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02238660 Zomig 16.9773 6.8633
02442655 Zolmitriptan 6.8583 6.8583
02313960 Teva-Zolmitriptan 6.8583 6.8583
02362988 Sandoz Zolmitriptan 6.8586 6.8586
02324229 PMS-Zolmitriptan 6.8586 6.8586
02421534 Nat-Zolmitriptan 6.8633 6.8633
02419521 Mint-Zolmitriptan 6.8583 6.8583
02399458 Mar-Zolmitriptan 6.8583 6.8583
02421623 Jamp-Zolmitriptan 6.8583 6.8583
02477106 Jamp Zolmitriptan 6.8583 6.8583
02458780 CCP-Zolmitriptan 6.8586 6.8586
02481030 Auro-Zolmitriptan 6.8633 6.8633
02380951 Apo-Zolmitriptan 6.8583 6.8583
02489392 NRA-Zolmitriptan 6.8600 6.8600
 

LU Clinical Criteria

NO  

EAP Criteria

Therapeutic Class Reimbursement Criteria
Migraine Drugs

Zolmitriptan

  • Brand(s): Zomig
  • Dosage Form/Strength: 2.5 mg tablet

  • Brand(s): Zomig Rapimelt
  • Dosage Form/Strength: 2.5 mg dispersible tablet

For the treatment of migraines with or without aura in patients who have failed an adequate trial of or experienced intolerance to all other oral triptans considered under the Exceptional Access Program. 

Duration of Approvals: 5 years 

Renewal requests may be considered for patients who continue to benefit from treatment. The physician must provide the frequency of triptan use.

EAP Drug Request Form:

Standard Form for EAP Drug Requests

Product Monograph

View Monograph